BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34933912)

  • 1. Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4.
    Mittal K; Kaur J; Sharma S; Sharma N; Wei G; Choudhary I; Imhansi-Jacob P; Maganti N; Pawar S; Rida P; Toss MS; Aleskandarany M; Janssen EA; Søiland H; Gupta MV; Reid MD; Rakha EA; Aneja R
    Mol Cancer Res; 2022 Apr; 20(4):596-606. PubMed ID: 34933912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. P4HA1/HIF1α feedback loop drives the glycolytic and malignant phenotypes of pancreatic cancer.
    Cao XP; Cao Y; Li WJ; Zhang HH; Zhu ZM
    Biochem Biophys Res Commun; 2019 Aug; 516(3):606-612. PubMed ID: 31239153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of HIF1α under Hypoxia by APE1/Ref-1 Impacts CA9 Expression: Dual Targeting in Patient-Derived 3D Pancreatic Cancer Models.
    Logsdon DP; Grimard M; Luo M; Shahda S; Jiang Y; Tong Y; Yu Z; Zyromski N; Schipani E; Carta F; Supuran CT; Korc M; Ivan M; Kelley MR; Fishel ML
    Mol Cancer Ther; 2016 Nov; 15(11):2722-2732. PubMed ID: 27535970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
    Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A potential signaling axis between RON kinase receptor and hypoxia-inducible factor-1 alpha in pancreatic cancer.
    Kato A; Ng S; Thangasamy A; Han H; Zhou W; Raeppel S; Fallon M; Guha S; Ammanamanchi S
    Mol Carcinog; 2021 Nov; 60(11):734-745. PubMed ID: 34347914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of HIF1A From Pancreatic Cancer Cells Increases Expression of PPP1R1B and Degradation of p53 to Promote Invasion and Metastasis.
    Tiwari A; Tashiro K; Dixit A; Soni A; Vogel K; Hall B; Shafqat I; Slaughter J; Param N; Le A; Saunders E; Paithane U; Garcia G; Campos AR; Zettervall J; Carlson M; Starr TK; Marahrens Y; Deshpande AJ; Commisso C; Provenzano PP; Bagchi A
    Gastroenterology; 2020 Nov; 159(5):1882-1897.e5. PubMed ID: 32768595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
    Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J
    Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non‑coding RNA PCED1B‑AS1 promotes pancreatic ductal adenocarcinoma progression by regulating the miR‑411‑3p/HIF‑1α axis.
    Zhang Y; Ma H; Chen C
    Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 34036383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SCF, regulated by HIF-1α, promotes pancreatic ductal adenocarcinoma cell progression.
    Gao C; Li S; Zhao T; Chen J; Ren H; Zhang H; Wang X; Lang M; Liu J; Gao S; Zhao X; Sheng J; Yuan Z; Hao J
    PLoS One; 2015; 10(3):e0121338. PubMed ID: 25799412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STK33 Promotes Growth and Progression of Pancreatic Cancer as a Critical Downstream Mediator of HIF1α.
    Kong F; Kong X; Du Y; Chen Y; Deng X; Zhu J; Du J; Li L; Jia Z; Xie D; Li Z; Xie K
    Cancer Res; 2017 Dec; 77(24):6851-6862. PubMed ID: 29038348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinoma.
    Mittal K; Ogden A; Reid MD; Rida PC; Varambally S; Aneja R
    Cell Cycle; 2015; 14(17):2798-809. PubMed ID: 26151406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LASP1 is a HIF1α target gene critical for metastasis of pancreatic cancer.
    Zhao T; Ren H; Li J; Chen J; Zhang H; Xin W; Sun Y; Sun L; Yang Y; Sun J; Wang X; Gao S; Huang C; Zhang H; Yang S; Hao J
    Cancer Res; 2015 Jan; 75(1):111-9. PubMed ID: 25385028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citron Rho-Interacting Serine/Threonine Kinase Promotes HIF1a-CypA Signaling and Growth of Human Pancreatic Adenocarcinoma.
    Cong L; Bai Z; Du Y; Cheng Y
    Biomed Res Int; 2020; 2020():9210891. PubMed ID: 32185224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia.
    Lee KE; Spata M; Bayne LJ; Buza EL; Durham AC; Allman D; Vonderheide RH; Simon MC
    Cancer Discov; 2016 Mar; 6(3):256-69. PubMed ID: 26715642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reciprocal regulation of LOXL2 and HIF1α drives the Warburg effect to support pancreatic cancer aggressiveness.
    Li R; Li H; Zhu L; Zhang X; Liu D; Li Q; Ni B; Hu L; Zhang Z; Zhang Y; Wang X; Jiang SH
    Cell Death Dis; 2021 Nov; 12(12):1106. PubMed ID: 34836938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular lumican inhibits pancreatic cancer cell growth and is associated with prolonged survival after surgery.
    Li X; Truty MA; Kang Y; Chopin-Laly X; Zhang R; Roife D; Chatterjee D; Lin E; Thomas RM; Wang H; Katz MH; Fleming JB
    Clin Cancer Res; 2014 Dec; 20(24):6529-40. PubMed ID: 25336691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer.
    Denu RA; Zasadil LM; Kanugh C; Laffin J; Weaver BA; Burkard ME
    BMC Cancer; 2016 Jan; 16():47. PubMed ID: 26832928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway.
    Xu F; Huang M; Chen Q; Niu Y; Hu Y; Hu P; Chen D; He C; Huang K; Zeng Z; Tang J; Wang F; Zhao Y; Wang C; Zhao G
    Cancer Res; 2021 Nov; 81(22):5678-5691. PubMed ID: 34593522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-inducible factor-1 promotes pancreatic ductal adenocarcinoma invasion and metastasis by activating transcription of the actin-bundling protein fascin.
    Zhao X; Gao S; Ren H; Sun W; Zhang H; Sun J; Yang S; Hao J
    Cancer Res; 2014 May; 74(9):2455-64. PubMed ID: 24599125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.